Luye Pharma Group (2186) Price & Analysis

Compare

1 Followers

2186 Stock Chart & Stats

Day’s Range― - ―

52-Week RangeHK$1.67 - HK$4.03

Previous CloseN/A

Volume7.60M

Average Volume (3M)126.13M

Market Cap

HK$13.49B

Enterprise ValueHK$13.05B

Total Cash (Recent Filing)HK$6.50B

Total Debt (Recent Filing)¥10.32B

Price to Earnings (P/E)26.8

Beta0.96

Next Earnings

Aug 27, 2025

EPS Estimate

0.08

Last Dividend Ex-Date

Jun 29, 2020

Dividend YieldN/A

Share Statistics

EPS (TTM)0.02

Shares Outstanding3,761,670,700

10 Day Avg. Volume104,083,270

30 Day Avg. Volume126,132,650

Financial Highlights & Ratios

PEG Ratio-1.34

Price to Book (P/B)1.01

Price to Sales (P/S)0.00

P/FCF Ratio29.29

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

HK$3.22

Price Target Upside-11.82% Downside

Rating ConsensusHold

Number of Analyst Covering1

Luye Pharma Group News

PremiumCompany Announcements

Luye Pharma Group Announces Successful AGM Results

2M ago

PremiumCompany Announcements

Luye Pharma Group Announces 2025 Annual General Meeting

3M ago

PremiumCompany Announcements

Luye Pharma Launches Rotigotine Patch in UK, Expands CNS Treatment Portfolio

4M ago

PremiumCompany Announcements

Luye Pharma’s Antidepressant Ruoxinlin® Gains Approval in Macao

4M ago

PremiumCompany Announcements

Luye Pharma’s Rivastigmine Patch Gains Approval in Japan

4M ago

PremiumCompany Announcements

Luye Pharma Reports Mixed Financial Results for 2024

4M ago

PremiumCompany Announcements

Luye Pharma Group Schedules Board Meeting to Approve Annual Results and Dividend

4M ago

PremiumThe Fly

Luye Pharma upgraded to Neutral from Sell at Goldman Sachs

4M ago

See All HK:2186 News

See All News >

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

33.13%

Insiders

1.93%

Mutual Funds

― Other Institutional Investors

62.67% Public Companies and

Individual Investors

Detailed Ownership Overview >

2186 FAQ

What was Luye Pharma Group ’s price range in the past 12 months?

Luye Pharma Group lowest stock price was HK$1.67 and its highest was HK$4.03 in the past 12 months.

What is Luye Pharma Group ’s market cap?

Luye Pharma Group ’s market cap is HK$13.49B.

When is Luye Pharma Group ’s upcoming earnings report date?

Luye Pharma Group ’s upcoming earnings report date is Aug 27, 2025 which is in 34 days.

How were Luye Pharma Group ’s earnings last quarter?

Luye Pharma Group released its earnings results on Mar 28, 2025. The company reported HK$0.022 earnings per share for the quarter, missing the consensus estimate of HK$0.12 by -HK$0.098.

Is Luye Pharma Group overvalued?

According to Wall Street analysts Luye Pharma Group ’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Luye Pharma Group pay dividends?

Luye Pharma Group pays a Annually dividend of HK$0.06 which represents an annual dividend yield of N/A. See more information on Luye Pharma Group dividends here

What is Luye Pharma Group ’s EPS estimate?

Luye Pharma Group ’s EPS estimate is 0.08.

How many shares outstanding does Luye Pharma Group have?

Luye Pharma Group has 3,761,670,700 shares outstanding.

What happened to Luye Pharma Group ’s price movement after its last earnings report?

Luye Pharma Group reported an EPS of HK$0.022 in its last earnings report, missing expectations of HK$0.12. Following the earnings report the stock price went up 2.058%.

Which hedge fund is a major shareholder of Luye Pharma Group ?

Currently, no hedge funds are holding shares in HK:2186

Luye Pharma Group Stock Smart Score

Underperform

Fundamentals

Return on Equity

3.53%

Trailing 12-Months

Asset Growth

12.87%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Luye Pharma Group

Luye Pharma Group (2186) is a multinational pharmaceutical company engaged in the development, production, and distribution of innovative medical products. The company operates in various sectors including oncology, cardiovascular, metabolism, and central nervous system (CNS) therapies. Luye Pharma is committed to advancing healthcare through its comprehensive portfolio of pharmaceuticals and its focus on research and development of new drugs and therapies.

2186 Stock 12 Month Forecast

Average Price Target

HK$3.22

▼(-11.82%Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"HK$1","6":"HK$6","2.25":"HK$2.25","3.5":"HK$3.5","4.75":"HK$4.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3.2184882535,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$3.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.2184882535,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$3.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.2184882535,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$3.22</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,2.25,3.5,4.75,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2021","6":"Jan<br/>2022","9":"Mar<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.58,3.552191404115385,3.524382808230769,3.496574212346154,3.4687656164615386,3.4409570205769233,3.4131484246923076,3.3853398288076924,3.357531232923077,3.3297226370384614,3.301914041153846,3.274105445269231,3.246296849384615,{"y":3.2184882535,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.58,3.552191404115385,3.524382808230769,3.496574212346154,3.4687656164615386,3.4409570205769233,3.4131484246923076,3.3853398288076924,3.357531232923077,3.3297226370384614,3.301914041153846,3.274105445269231,3.246296849384615,{"y":3.2184882535,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.58,3.552191404115385,3.524382808230769,3.496574212346154,3.4687656164615386,3.4409570205769233,3.4131484246923076,3.3853398288076924,3.357531232923077,3.3297226370384614,3.301914041153846,3.274105445269231,3.246296849384615,{"y":3.2184882535,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.86,"date":1617235200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4.86,"date":1617235200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.72,"date":1619827200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.11,"date":1625097600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":4.25,"date":1627776000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":4.1,"date":1630454400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.56,"date":1640995200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.73,"date":1704067200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.81,"date":1722470400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.34,"date":1740787200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":2.2,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.45,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.58,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >